Committed to responsible pain management
Developing innovative and differentiated products for people suffering from pain
At Collegium Pharmaceutical we are committed to being the leader in responsible pain management. We have developed a portfolio of meaningfully differentiated products for use in the treatment of moderate to severe pain.
News and Press
Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent LitigationRead More September 30, 2020
Collegium Appoints Rita Balice-Gordon to its Board of DirectorsRead More September 25, 2020